16 debate as recomendações de maior impacto da diretriz esc 2023 de síndrome coronariana aguda
Published 11 months ago • 21 plays • Length 0:29Download video MP4
Download video MP3
Similar videos
-
2:21
ascent: a randomized phase iii study of sacituzumab govitecan vs treatment of physician’s choice
-
33:47
ideal conference debate: "surgical rcts - not always needed?"
-
0:51
why should we consider harm reduction as a complimentary measure for cardiac disease?
-
11:23
therap study: lu-psma vs. cabazitaxel #asco20 #anzup
-
9:54
idea trial: 3 vs 6 months of adjuvant therapy in crc
-
18:36
the comfort corner #3: dialogue with prof. stein kaasa, hosted by martin harutyunyan
-
13:46
debate 3: salvage therapy for mcrc? - tas-102
-
10:48
climate change debate | kriti joshi | opposition
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
15:51
stage iii colon cancer: can we refine the selection for adjuvant treatment?
-
0:31
debate: foco no acc 2024: síndrome coronária aguda
-
5:55
quantitative vs qualitative research: when to use each method
-
59:08
health care, session 3, cancer in iowa
-
2:18
dr doria assesses the impact on asuncion of c/can’s multi-sectoral approach
-
7:17
3 key differences between glanzmann thrombasthenia and bernard-soulier syndrome|| #ristocetintest
-
15:40
case: switching booster - not always trivial | dario cattaneo
-
0:31
debate: insuficiência cardíaca - atualizações e controvérsias
-
10:22
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - total neoadjuvant
-
5:05
winning the hiv battle#prep
-
0:31
all of us against cancer k13 30 16x9 youtube
-
34:21
indication and regimens including ablative vs. ric nma